SNNA - Sienna Biopharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
Operating Expenses
Research Development
26,770
51,592
30,484
10,993
Selling General and Administrative
22,706
24,906
18,087
9,696
Total Operating Expenses
49,476
76,498
48,571
20,689
Operating Income or Loss
-49,476
-76,498
-48,571
-20,689
Interest Expense
-
-
-
568
Total Other Income/Expenses Net
-3,093
3,027
-2,264
95
Income Before Tax
-52,569
-73,471
-50,835
-21,162
Income Tax Expense
-4,618
0
-290
-
Income from Continuing Operations
-47,951
-73,471
-50,545
-21,162
Net Income
-47,951
-73,471
-50,545
-21,162
Net Income available to common shareholders
-47,951
-73,471
-50,545
-21,162
Basic EPS
-
-3.59
-5.19
-1.89
Diluted EPS
-
-3.59
-5.19
-1.89
Basic Average Shares
-
20,450
9,735
11,177
Diluted Average Shares
-
20,450
9,735
11,177
EBITDA
-
-76,341
-48,451
-20,527